Xu, P., Zhu, Y., Shi, Z., Wang, L., Cheng, S., Qian, Y., Zhao, Y., He, Y., Yi, H., Ou-yang, B., Jiang, X., Li, B., Song, Q., Mu, R., Zhao, W. (2025). A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood.2025028649